跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 34,675 条关于
“severe fatty liver”
全部
34,675
临床试验
24,895
药物
712
机构
89
资讯
8,979
去年
OPKO Health and Entera Bio Advance First-in-Class Oral Dual GLP-1/Glucagon Tablet for Obesity Treatment
上个月
Weight Loss Alone May Not Prevent Type 2 Diabetes in High-Risk Metabolic Cluster, Study Finds
去年
DT-109: Novel Glycine-Based Compound Shows Dual Efficacy Against Atherosclerosis and MASH
去年
Wegovy Shows Promise in Treating Fatty Liver Disease MASH in Phase 3 Trial
去年
Beyond Weight Loss: Semaglutide Shows Promise in Treating Diverse Conditions
去年
OliX and Eli Lilly Forge $630M Deal for Novel RNAi Therapy Targeting MASH and Obesity
去年
Sagimet Biosciences Advances Denifanstat for MASH, Secures Buy Ratings
去年
Lanifibranor Shows Promise in MASH Patients with Type 2 Diabetes: LEGEND Trial Results
去年
FDA Approves Rezdiffra (resmetirom) for NASH with Liver Fibrosis
去年
Novo Nordisk's Wegovy Shows Promise in MASH Trial, Paving Way for Regulatory Filings
第 1 页,共 898 页
上一页
下一页